Nj State Employees Deferred Compensation Plan Zai Lab LTD Transaction History
Nj State Employees Deferred Compensation Plan
- $800 Million
- Q4 2024
A detailed history of Nj State Employees Deferred Compensation Plan transactions in Zai Lab LTD stock. As of the latest transaction made, Nj State Employees Deferred Compensation Plan holds 11,300 shares of ZLAB stock, worth $403,071. This represents 0.04% of its overall portfolio holdings.
Number of Shares
11,300
Previous 11,300
-0.0%
Holding current value
$403,071
Previous $272,000
8.46%
% of portfolio
0.04%
Previous 0.03%
Shares
1 transactions
Others Institutions Holding ZLAB
# of Institutions
145Shares Held
46.3MCall Options Held
103KPut Options Held
439K-
Janus Henderson Group PLC London, X06.57MShares$234 Million0.09% of portfolio
-
Capital World Investors Los Angeles, CA6.43MShares$229 Million0.03% of portfolio
-
Morgan Stanley New York, NY3.17MShares$113 Million0.01% of portfolio
-
Rtw Investments, LP New York, NY2.51MShares$89.5 Million1.07% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD2.35MShares$84 Million0.01% of portfolio
About Zai Lab Ltd
- Ticker ZLAB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 97,908,704
- Market Cap $3.49B
- Description
- Zai Lab Limited develops and commercializes therapies to treat oncology, autoimmune disorders, infectious diseases, and neuroscience primarily in Mainland China and Hong Kong. The company's commercial products include Zejula, a once-daily small-molecule poly polymerase 1/2 inhibitor; Optune, a device that delivers tumor treating fields; NUZYRA f...